Page last updated: 2024-09-03

bdf 9148 and Cardiac Failure

bdf 9148 has been researched along with Cardiac Failure in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (88.89)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corbly, AK; Gill, RM; Jones, BD; Shen, W; Steinberg, MI; Zhang, JP1
Amos, GJ; Hoey, A; Ravens, U1
Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R1
Arnold, G; Böhm, M; Flesch, M; Frank, K; Kuhn-Regnier, F; Schiffer, F; Schwinger, RH; Südkamp, M1
Bavendiek, U; Brixius, K; Erdmann, E; Frank, K; Gross, A; Müller-Ehmsen, J; Pietsch, M; Reuter, H; Schwinger, RH1
Brixius, K; Frank, K; Müller-Ehmsen, J; Schwinger, RH1
Brixius, K; Müller-Ehmsen, J; Schwinger, RH1
Fransua, M; Frishman, WH; Yashar, PR1
Doggrell, SA; Nand, V1

Reviews

1 review(s) available for bdf 9148 and Cardiac Failure

ArticleYear
The sodium-calcium ion membrane exchanger: physiologic significance and pharmacologic implications.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:5

    Topics: Azetidines; Calcium; Cardiotonic Agents; Heart Failure; Myocardial Ischemia; Piperazines; Protein Conformation; Sodium; Sodium-Calcium Exchanger

1998

Other Studies

8 other study(ies) available for bdf 9148 and Cardiac Failure

ArticleYear
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:2

    Topics: Animals; Azetidines; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Sodium Channel Agonists; Ventricular Function, Left

2002
Comparison of the action potential prolonging and positive inotropic activity of DPI 201-106 and BDF 9148 in human ventricular myocardium.
    Journal of molecular and cellular cardiology, 1994, Volume: 26, Issue:8

    Topics: Action Potentials; Aged; Azetidines; Biological Transport; Calcium; Cardiotonic Agents; Carrier Proteins; Electrocardiography; Female; Heart Conduction System; Heart Failure; Heart Ventricles; Humans; Intracellular Fluid; Male; Microelectrodes; Middle Aged; Myocardial Contraction; Papillary Muscles; Piperazines; Sodium; Sodium Channels; Sodium-Calcium Exchanger

1994
Mechanism of action of OPC-8490 in human ventricular myocardium.
    Circulation, 1996, Feb-15, Volume: 93, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine

1996
Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium.
    Circulation, 1996, Sep-01, Volume: 94, Issue:5

    Topics: Adult; Atrial Natriuretic Factor; Azetidines; Calcium; Carrier Proteins; Female; Heart Failure; Humans; Immunohistochemistry; Isoproterenol; Male; Middle Aged; RNA, Messenger; Sodium; Sodium-Calcium Exchanger

1996
Altered inotropism in the failing human myocardium.
    Basic research in cardiology, 1996, Volume: 91 Suppl 2

    Topics: Adrenergic beta-Agonists; Azetidines; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiotonic Agents; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Failure; Humans; In Vitro Techniques; Indoles; Isoproterenol; Myocardial Contraction; Myocardium; Ouabain; Sarcoplasmic Reticulum; Sodium

1996
Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:4

    Topics: Adrenergic beta-Agonists; Antiporters; Azetidines; Calcium; Cardiotonic Agents; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Failure; Heart Transplantation; Humans; Isoproterenol; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Papillary Muscles; Sodium; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase

1997
Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:5

    Topics: Azetidines; Cardiotonic Agents; Cell Membrane; Electric Stimulation; Heart; Heart Failure; Humans; Isoproterenol; Myocardial Contraction; Myocardium; Papillary Muscles; Receptors, Adrenergic, beta; Ventricular Function, Left

1998
Effects of BDF 9148 on the action potentials and contractions of left ventricles from normo- and hypertensive rats.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:3

    Topics: Action Potentials; Animals; Azetidines; Cardiotonic Agents; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Myocardial Contraction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Channels; Ventricular Function, Left

1999